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Abstract
Alcohol exposure triggers changes in gene expression and biological pathways in human brain. We explored
alterations in gene expression in the Pre-Frontal Cortex (PFC) of 65 alcoholics and 73 controls of European descent,
and identified 129 genes that showed altered expression (FDR < 0.05) in subjects with alcohol dependence.
Differentially expressed genes were enriched for pathways related to interferon signaling and Growth Arrest and DNA
Damage-inducible 45 (GADD45) signaling. A coexpression module (thistle2) identified by weighted gene co-
expression network analysis (WGCNA) was significantly correlated with alcohol dependence, alcohol consumption,
and AUDIT scores. Genes in the thistle2 module were enriched with genes related to calcium signaling pathways and
showed significant downregulation of these pathways, as well as enrichment for biological processes related to
nicotine response and opioid signaling. A second module (brown4) showed significant upregulation of pathways
related to immune signaling. Expression quantitative trait loci (eQTLs) for genes in the brown4 module were also
enriched for genetic associations with alcohol dependence and alcohol consumption in large genome-wide studies
included in the Psychiatric Genetic Consortium and the UK Biobank’s alcohol consumption dataset. By leveraging
multi-omics data, this transcriptome analysis has identified genes and biological pathways that could provide insight
for identifying therapeutic targets for alcohol dependence.
Introduction
Alcohol dependence (AD) can be defined as a cluster of
physiological, behavioral, and cognitive phenomena in
which the use of alcohol takes a much higher priority for a
given individual than other behaviors that once had
greater value (American Psychiatric Association 1994)1.
The development of AD is characterized by frequent
episodes of intoxication, preoccupation with alcohol, use
of alcohol despite adverse consequences, compulsion to
seek and consume alcohol, loss of control in limiting
alcohol intake, and emergence of a negative emotional
state in the absence of the drug (American Psychiatric
Association 1994)1. The changes in behavioral priorities
not only results in increased morbidity and mortality, it is
also a substantial social and economic burden on indivi-
dual families and the nation2.
In individuals with alcohol dependence, there is a
complex interplay between genetic background, environ-
mental factors, and history of alcohol exposure3. Alcohol
crosses the blood brain barrier and triggers changes in the
central nervous system4, including transcriptional
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changes in many different regions of the brain5–9. The
transcriptional effects of long-term alcohol consumption
are associated with pathways involved in the neuro-
immune system, neurotoxicity, and changes in neuro-
plasticity6,7,9. Transcriptomes from complex tissues, such
as human brain, may be organized into networks of co-
expressed genes that better reflect the biological functions
and organization of the tissue7–14. Application of bioin-
formatics techniques, such as weighted gene co-
expression network analysis (WGCNA)15, has uncovered
networks associated with alcohol dependence8,9. How-
ever, past studies were performed on small numbers of
AD cases, thus limiting the statistical power to detect
small changes in alcohol-induced gene expression. In this
study, we utilized massively parallel sequencing of RNA
transcripts from postmortem human prefrontal cortex
(PFC) of 65 alcoholics and 73 controls of European des-
cent to explore transcriptional networks and genetic
variation and identified groups of coexpressed genes
associated with alcohol dependence. Our analysis pro-
vides systems-level evidence of genetic networks within
the PFC that contribute to the pathophysiology of alcohol
drinking behavior in humans.
Materials and methods
Case selection and postmortem tissue collection
Human autopsy brain samples were obtained from the
New South Wales Tissue Resource Centre at the Uni-
versity of Sydney (http://sydney.edu.au/medicine/
pathology/btrc/). Fresh frozen samples of the superior
frontal gyrus (Brodmann area 8; referred to as prefrontal
cortex (PFC) in this manuscript) were collected from each
postmortem sample. Brain tissue was sectioned at 3 mm
intervals in the coronal plane. Alcohol-dependent diag-
noses were confirmed by physician interviews, review of
hospital medical records, questionnaires to next-of-kin,
and from pathology, radiology, and neuropsychology
reports. Tissue samples were matched as closely as pos-
sible according to age, sex, post-mortem interval, pH of
tissue, disease classification, and cause of death. To be
included as part of the alcohol-dependent cohort, subjects
had to meet the following criteria: greater than 18 years of
age, no head injury at time of death, lack of developmental
disorder, no recent cerebral stroke, no history of other
psychiatric or neurological disorders, no history of intra-
venous or polydrug abuse, negative screen for AIDS and
hepatitis B/C, post-mortem interval within 48 h, and
diagnosis of AD meeting the DSM-IV criteria1.
Sample preparation
The Qiagen RNeasy and Lipid Tissue kit (Qiagen,
Valencia, CA, USA) was used to extract total RNA from
human PFC brain tissue, and RNA concentration was
measured with a NanoDrop 8000 spectrophotometer
(ThermoFisher Scientific). An Agilent Bioanalyzer (Agi-
lent Technologies, Santa Clara, CA, USA) was used to test
the integrity of RNA samples. Samples with an RNA
integrity number (RIN) < 5.5 were removed from futher
analyses. Sixty samples were processed at the Waggoner
Center for Alcohol and Addiction Research (WCAAR),
The University of Texas at Austin while 83 samples were
processed at the Ronald M. Loeb Center for Alzheimer
disease, Icahn School of Medicine at Mount Sinai. Details
about the library preparation and sequencing is provided
in the supplementary document.
Mapping and quantification of gene expression
Raw reads were aligned to human genome 19 (hg19)
using STAR aligner (version 2.5.3.a)16. We used QC tools
RSeQC (http://code.google.com/p/rseqc/) and Picard
(https://broadinstitute.github.io/picard/) to evaluate RNA
sequence quality including the %GC, %duplicates, gene
body coverage, unsupervised clustering, and the library
complexity. We used the Picard “MarkDuplicates” option
to flag and remove duplicate reads. Gene quantification
was performed with featureCounts (SUBREAD package;
release 1.6.0)17 using Gencode annotations (Release 19
(GRCh37.p13)).
Selection of covariates to for analyses
Linear regression
We first performed a linear regression with alcohol
dependence as a dependent variable to identify possible
covariates (e.g. sex, age, PMI). The mean age of AD
subjects was 55.65 years and was not significantly differ-
ent from the age of control subjects (54.96) (Table 1).
There was no significant difference in distribution of RIN
and brain pH between cases and controls (Table 1).
Postmortem interval (PMI) was significantly lower for the
alcohol-dependent subjects.
Variance partition analysis
We used the variancePartition package18 in R to cal-
culate the proportion of variance in RNA expression
explained by known covariates such as age, gender, RIN
Table 1 Demographic profile of alcohol-dependent and
control subjects
Trait Alcohol Dependent (N= 65) Control (N= 73)
Male (%) 51 (78%) 60 (82%)
Mean Age (SD) (yrs) 55.65 (11.81) 54.96 (12.11)
Mean PMI (SD) (hrs) 33.66 (15.59)* 26.63 (13.25)
Brain pH (SD) 6.54 (0.23) 6.58 (0.29)
RIN (SD) 6.84 (0.96) 7.0 (1.01)
*P value= 0.0049
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and PMI, using the variancePartition package in R. The
variancePartition18 package uses linear mixed model
based statistical methods to quantify the contribution of
multiple sources of variation and identify the covariates
that required correction in the final analysis. Supple-
mentary figure 1A shows violin plots depicting drivers of
variation in gene expression data without accounting for
covariates. The figure shows that sequencing batch is a
major driver of variation in a large proportion of genes,
while RIN and sex have large effects on only a few genes.
We used the voom function in the Limma package
(https://www.bioconductor.org/packages/devel/bioc/
vignettes/limma/) to account for the effect of sequencing
batch, RIN, age, sex and PMI on gene expression. After
removing the effects of these covariates, alcohol-related
phenotypes explained the largest proportion of the
remaining variation in gene expression (Supplementry
Figure 1B).
Differential gene expression analysis
Gene-level analyses started with the featureCounts-
derived sample-by-gene read count matrix. The basic
normalization and adjustment pipeline for the expression
data matrix consisted of: (i) removal of low expression
genes (<1 CPM in > 50% of the individuals); (ii) differ-
ential gene expression analysis based upon adjustment for
the chosen covariates. We filtered out all genes with lower
expression in a substantial fraction of the cohort, with
18,463 genes with at least 1 CPM in at least 50% of the
individuals; note that only these genes were carried for-
ward in all subsequent analyses. The following design was
used for the final differential expression analysis using the
DeSeq219 package as implimented in R: gene expression ~
DSM4 alcohol classification+ sex+ age+ PMI+ RIN+
batch.
Pathway analyses of differential expression
Ingenuity® Pathway Analysis (IPA®) was used to per-
form pathway, canonical pathways, and causal network
analysis. All genes that passed the threshold of
significance at 25% FDR were included in the analysis
Table 2.
Gene ontology analysis
Gene ontology analyses were performed using the
clusterProfiler package20 as implemented in R. All dif-
ferentially expressed genes that passed the threshold of
significance at 25% FDR were included in the analysis.
Results for the enrichment analysis were extracted and
plotted using the ggplot2 package in R.
Gene co-expression analysis
Scale-free co-expression networks were constructed
using the weighted gene coexpression network analysis
(WGCNA) package in R15. WGCNA provides a global
perspective, emphasizing the correlation between genes to
classify different molecular groupings, rather than focus-
ing on individual genes. WGCNA defines modules using a
dynamic tree-cutting algorithm based on hierarchical
clustering of expression values (minimum module size=
100, cutting height= 0.99, deepSplit=TRUE). The net-
works were constructed at a soft power of 14 at which the
scale-free topology fit index reached 0.90 (Supplementary
Figure 2B). We further merged modules that had similar
co-expression patterns by calculating the eigengenes and
merging those having a correlation > 75% (Supplementary
Figure 2C). Correlation of module eigengenes with alco-
hol dependence, alcohol consumption, AUDIT scores and
number of years of drinking (module-trait correlation
analysis) was evaluated using Spearman’s rank correlation
analysis. We used the DSM4 criteria for alcohol depen-
dence classification as provided by the New South Wales
Tissue Resource Centre at the University of Sydney. For
each individual in the RNA-Seq dataset a module eigen
value was calculated for each module. This module eigen
value was used to perform the correlation analysis of the
traits (e.g. alcohol dependence, alcohol consumption and
Audit scores) with each whole module. Digital deconvo-
lution showed no significant differences in the percentage
of neurons, astrocytes and microglia in the PFC of alco-
holics and controls (Supplementary Figure 3)21; therefore
we did not perform any correction for cell-type hetero-
geneity. Assigned modules were functionally annotated
against known molecular/functional categories and
pathways using Ingenuity Pathway Analysis (IPA).
GWAS enrichment analysis
The summary statistics from a GWAS of alcohol
dependence (PGC-AD) were provided by the Psychiatric
Genetics Consortium Substance Use Dependence work-
ing group22 (Walters et al.). Summary statistics for the
UKBB alcohol consumption (UKBB-AC) GWAS23 were
provided by Dr. Toni Clarke. We also downloaded the
summary statistics for Tobacco and Genetics (TAG)
Consortium’s GWAS24 of cigarettes per day from the
PGC website (https://www.med.unc.edu/pgc/results-and-
downloads). SNPs from the PGC-AD and UKBB-AC
studies were mapped to PFC expression quantitative trait
loci (eQTLs) in 461 post-mortem brains from the Reli-
gious Orders Study and Memory and Aging Project (ROS/
MAP)25 (Bennett et al). Enrichment analysis was per-
formed for SNPs meeting the criteria of eQTL P < 5 ×
10−8 in the ROSMAP dataset and tested for over-
representation in GWAS of AD (PGC-AD), alcohol con-
sumption (UKBB-AC) and TAG-CPD. Since there are a
few loci that passed the genome-wide significance
threshold in alcohol and smoking GWAS analysis, we
tested the polygenicity of alcoholism and smoking by
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exploring the overenrichment in variants that passed
nominal threshold of significance in these datasets. The
enrichment analysis was focused on eQTLs for the genes
within modules that were correlated with AD in the
module-trait correlation analysis. The two modules
(thistle and brown4) that showed significant enrichment
(p ≤ 0.05) in the Fisher exact test were subjected to
100,000 permutations to report the final P value of
enrichment. We also performed the gene-based analysis
by Multi-marker Analysis of GenoMic Annotation
(MAGMA)26 on summary statistics of PGC-AD, UKBB-
AC and TAG-CPD GWAS using Functional Mapping and
Annotation of GWAS (FUMA-GWAS)27. The summary
statistics of this gene-based analysis were overlaid on the
IPA networks to identify the genes in these networks that
also have nominal to moderate evidence of genetic
contributions.
Results
Differential expression analysis
Analysis of PFC tissue derived from 65 alcoholics and
73 controls identified 827 differentially expressed genes at
25% FDR, 298 genes at 10% FDR and 129 genes at 5% FDR
(Fig. 1a, Supplemental Table 1; protein coding genes
only). Transient Receptor Potential Cation Channel Sub-
family C Member 3 (TRPC3) was the top differentially
expressed gene with significantly lower expression in
alcohol-dependent subjects (FC 0.82; p= 4.6 × 10−9),
while Kinesin Family Member 19 (KFM19) showed sig-
nificantly higher expression in alcohol-dependent subjects
(FC 1.24; p= 5.7 × 10−9). IPA analysis of the differentially
expressed genes (FDR < 25%) showed significant enrich-
ment for pathways involved in interferon signaling,
GADD45 signaling, and other immune-related pathways
(Fig. 1b). Gene-ontology enrichment analysis using clus-
teProfiler mapped a large proportion of genes to biolo-
gical processes involved in blood coagulation and fluid
transport (Fig. 1c). The network analysis in IPA mapped
the significant genes to networks involved in neurode-
generative disorders and organismal injury. Several genes
that were part of this network were also nominally sig-
nificant (p < 0.05) in the PGC-AD and UKBB-AC GWAS
(Fig. 1d).
Identification of gene co-expression networks and
modules
After correcting for the effects of batch, age, and RIN,
the hierarchical clustering of expression data from nearly
18,000 genes generated 27 different modules (Supple-
mentary Figure 1). Trait-module correlation analyses
identified five modules that were significantly correlated
to at least one alcohol-related trait (Fig. 2). Of these five
modules, the thistle2 module (containing 72 genes), was
negatively correlated with alcohol dependence and other
alcohol-related traits. The brown4 module (containing of
795 genes) was positively correlated with AD, AUDIT,
alcohol consumption and duration of alcohol use.
Thistle2 module
Pathway enrichment analysis of the thistle2 module
showed a significant downregulation of pathways related
to calcium signaling (Fig. 3a). Gene-ontology enrichment
analysis using the clusterpProfiler showed significant
enrichment for biological processes involved in “response
to nicotine” and “excitatory postsynaptic potential” (Fig.
3b). Several genes in the thistle2 module that were sig-
nificantly downregulated in the PFC of alcohol-dependent
subjects. Differentially expressed genes in the thistle2
module mapped to networks involved in G-protein cou-
pled receptor signaling, calcium signaling, and opioid
signaling (Fig. 3c). Cholinergic Receptor Nicotinic Alpha
subunits 6 and 2 (CHRNA6 UKBB-AC P= 7.60 × 10−3;
CHRNA2 PGC-AD P= 1.4 × 10−2), Meningioma 1 (MN1,
PGC-AD P= 9.1 × 10−3) and Hyaluronan And Pro-
teoglycan Link Protein 1 (HAPLN1, UKBB-AC P= 1.9 ×
10−2) are some exmples where differntialy expressed
genes in thistle 2 module also showed some evidence of
genetic contribution towards alcohol consumption or
dependence.
Table 2 Results of GWAS enrichment analysis in modules correlated with alcohol dependence and alcohol consumption
RNA-Seq data (N= 138) GWAS data
Module trait correlation GWAS P 0.05, eQTL P < 5 × 10−8
ID AD P Audit P AC P PGC-AD UKBB-AC TAG-CPD
Thistle2 −0.28 9.00E-04 −0.25 3.00E-03 −0.22 9.00E-03 1.50E-02a 1.30E-02a 5.52E-01a
Brown4 0.18 4.00E-02 0.14 1.00E-01 0.12 1.00E-01 4.20E-03b 2.28E-01b 4.81E-03b
AD alcohol dependence, Audit audit scores, AC alcohol consumption
a Permuted P value for the left-tail Fisher’s exact test (under-enriched)
b Permuted P value to test right-tail Fisher’s exact test (over-enriched)
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Brown4 module
Pathway analysis for differentially expressed genes in the
brown4 module showed significant enrichment for
Growth Arrest and DNA Damage (GADD45) signaling
and for biological processes related to the inflammatory
response (Fig. 4). Other genes that were also significantly
upregulated in the PFC of alcoholics mapped to networks
involved in infectious and respiratory diseases.
GWAS enrichment analysis
GWAS enrichment analysis of significant eQTLs (P ≤
5 × 10−8) for all genes in the top 5 modules (ranked by P
value in module-trait correlation analysis), showed evi-
dence of enrichment for SNPs associated with AD
(GWAS p ≤ 0.05) in PGC-AD and alcohol consumption in
UKBB-AC datasets (Table 2). The brown4 module was
also enriched for GWAS association in the TAG-CPD
dataset. The thistle2 module did not show enrichment of
GWAS association. Surprisingly, genes in the thistle2
modules were significantly depleted for GWAS signals in
the PGC-AD and UKBB-AC GWAS analyses. This finding
was confirmed by permutation analysis.
Discussion
To our knowledge, this is the largest transcriptome
analysis comparing PFC of alcohol-dependent cases and
controls. The present study identified 129 genes (FDR <
0.05) that were differentially expressed in alcohol-
dependent subjects (Supplementary table 1). FKBP5, a
well studied gene that is asoociated with alcohol use28–31,
showed increased expression in the PFC of alcohol-
dependent subjects in our differential gene expression
analysis (l2FC 0.27; P= 4.57 × 10
−7). Other studies have
also shown that FKBP5 plays a role in alcohol drinking
Fig. 1 Top genes, pathways and networks from differential gene expression in DLFPC region from 68 alcoholics and 70 controls. a Volcano
plot showing top differentially expressed genes among cases and controls. b The genes passing FDR threshold of 20% were inputted to IPA for
pathway enrichment analysis. The figure shows some of the top pathways identified by IPA. P values here are from right tail Fisher’s exact test. c
Enrichment analysis of gene ontology “biological process” terms. Color depicts the qvalues with red being the strongest evidence of enrichment. d
Network analysis on top genes (FDR <=20%) mapped to networks involved in the neurodegenerative disorders and organismal injuries. P value
under the gene is the uncorrected p value for differential expression among alcoholics and controls. The nominally significant genes in the UKBB-alc
and PGC-SUD GWAS are highlighted with purple border and blue annotation
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behaviors in rodents28,29 and humans32. FKBP5 encodes
FK506-binding protein 5, a glucocorticoid receptor (GR)-
binding protein implicated in various psychiatric dis-
orders and alcohol withdrawal severity30. Qiu and col-
leagues30 reported that Fkbp5 KO mice exhibited
increased alcohol consumption compared with wild-type
mice. Another study has shown that the absence of Fkbp5
enhances sensitivity to alcohol withdrawal in mice33.
Recent findings also suggested that Fkbp5 expression in
mesocorticolimbic dopaminergic regions is associated
with early life-stress mediated sensitivity to alcohol
drinking and that there is a gene–environment interaction
among FKBP5 genotype and parent–child relationship
that influences alcohol drinking.
Genes showing significant differences in expression
between alcohol-dependent subjects and controls were
enriched in pathways related to interferon and
GADD45 signaling (Fig. 1b). Interferons are cytokines
that have antiviral, antiproliferative, and
immunomodulatory effects and the interferon pathway
plays a critical role in human innate and adaptive immune
responses34. Our pathway analysis results are consistent
with earlier findings showing induction of innate immune
genes by stress and drug abuse35. Furthermore, mRNA
expression studies in human brain showed significant
changes in expression of genes related to immune or
inflammatory responses in hippocampus7 and nucleus
accumbens8. The neuroinflammation associated with
chronic alcohol exposure and withdrawal may be attrib-
uted to microglial activation and is associated with the
neuropathology of chronic alcohol exposure36. Differen-
tially expressed genes (FDR < 25%) also mapped to net-
works associated with neurodegenerative disorders and
organismal injury (Fig. 1d). Many differentially expressed
genes in this network are involved in nervous system
development and function. Specifically TRPC3 and cal-
cium dependent protein kinase 4 (CAMK4) are involved
in excitatory post-synaptic current while Ampa receptor,
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Glutamate Ionotropic receptor AMPA type subunit 4
(GRIA4), Calcium dependent protein kinase ii (CaMKII)
and CAMK4 are involved in synaptic transmission.
Although we identified several genes that were differ-
entially expressed in the PFC of alcohol-dependent
subjects, the variance explained by individual genes was
very small (0.15–1%). The differential expression observed
here is smaller than that reported in earlier differential
expression studies of alcoholism, but it is consistent with
differential expression studies of larger sample size37. For
Fig. 3 Enrichment analysis of genes in thistle2 module that are differentially expressed in alcoholics and controls. a More than 50% of genes
in calcium signaling pathways were found to be downregulated in the thistle2 module. b Enrichment analysis for GO:BP terms showed
downregulation of genes related to response to nicotine and postsynaptic potential. c Nearly 15 genes mapped to network related to amino-acid
metabolism with many genes that were involved in G-protein coupled receptor signaling, calcium signaling and opioid signaling pathway. The
nominally significant genes in the UKBB-alc and PGC-SUD GWAS are marked with red boundaries (ADCY5 P= 7.07 × 10−7 in UKBB-AC, ADCY7, P=
2.2 × 10−4 in UKBB-AC), IL12B, P= 1.1 × 10−2 in PGC-AD, PIK3C2G, P= 6.8 × 10−3 in UKBB-AC, PIK3R4, P= 3.4 × 10−2 in PGC-AD, CHRNA6 in UKBB-AC P
= 7.60 × 10−3, CHRNA2 in PGC-AD P= 1.4 × 10−2, MN1 in PGC-AD P= 9.1 × 10−3 and HAPLN1 in UKBB-AC P= 1.9 × 10−2)
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example, the CommonMind consortium reported similar
fold changes in the differential expression study of schi-
zophrenia and they showed that their observation is
consistent with plausible models for average differential
gene expression and the polygenic inheritance of schizo-
phrenia. The polygenicity of AD has also been observed
by the GWAS of alcoholism and other complex
behavioral/psychiatric disorders22,38–41, and it was
demonstrated that effect size for each individual genetic
variant is very small. Studies that used a co-expression
network approach also showed that alcohol dependence is
shaped, in part, by persistent alterations in networks of
co-expressed genes that collectively mediate excessive
drinking and other alcohol-dependent phenotypes8,9.
Fig. 4 Enrichment analysis of brown4 module genes that were differentially expressed (FDR* < 0.05) among alcoholics and controls. a
Pathway analysis showed significant upregulation of genes related immune signaling and metabolism. b Enrichment analysis for GO:BP terms
showed enrichment of genes related to inflamatory response. c The genes in the brown4 module mapped to network involved in infectious and
respiratory diseases. The genes that were nominally significant in the UKBB-Alc and PGC-SUD GWAS are highlighted with red boundaries
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These and other studies also demonstrated that the gene
network structure is significantly correlated with lifetime
alcohol consumption in addition to an overall loss in
network structure; furthermore, the neurobiology of
alcohol dependence may be due to altered covariation of
gene modules, rather than discrete changes in differen-
tially expressed genes across the transcriptome9,13.
Trait-module correlation analysis for the thistle2 mod-
ule showed a significant negative correlation with alcohol
dependence (−0.28, P= 9.0 × 10−4), alcohol consumption
(−0.22, P= 9.0 × 10−3), and AUDIT score (−0.25, P=
3.0 × 10−3), while the brown4 module showed a positive
correlation (0.18, P= 4.0 × 10−2) with alcohol dependence
(Fig. 2; Table 2). The salmon4 module was associated with
the total number of drinking years (−0.24, P= 4.0 ×
10−3), independent of the age of the subjects. Genes in the
thistle2 module were significantly downregulated in the
PFC from alcoholics. Many genes in the thistle2 module
mapped to networks involved in opioid signaling and
nicotine response, highlighting the importance of this
module in addiction-related traits. Pathway analysis
showed that all genes that overlapped with genes involved
in calcium signaling were significantly downregulated
(Fig. 3a). Acute ethanol exposure has been shown to
inhibit Ca2+ currents induced by PKC-dependent phos-
phorylation of mGluR5 in neurons42. Early studies in
PC12 cell cultures also showed that ethanol has a sig-
nificant inhibitory effect on the influx of Ca2+ through L-
type voltage-gated Ca2+ channels43. Alcohol exposure
also modulates Ca2+ signaling between astrocytes and
neurons44 (Warden et al.), and Ca2+ acts as a second
messenger that controls multiple processes in immune
cells, including chemotaxis and secretion of pro- and anti-
inflammatory cytokines. Our analyses provide further
evidence that alcohol exposure alters Ca2+ signaling in
the brains of alcoholics and could potentially alter com-
munication between neurons and brain immune cells.
Another module that correlated with alcohol dependence,
brown4, was also enriched in immune response and
infectious diseases, providing additional evidence for the
role of the neuroimmune system in the etiology of alcohol
dependence. Some of the differentially expressed genes in
this network were also statistical significant in the gene-
based tests (RASD1, UKBB-AC, P= 1.64 × 10−5 and
ARID5A, UKBB-AC, P 1.4 × 10−3). The differentially
expressed FKBP5 gene was also part of the brown module,
but it was not identified as hub gene according to intra-
modular connectivity (supplementary table 2).
Enrichment analysis of nominally significant GWAS
variants (p < 0.05) that were also eQTLs (p < 5 × 10−8) for
genes in the thistle2 module showed significant under
enrichment in the two-tail Fisher test (Table 2). The
under-enrichment remained significant even after 100,000
permutations. This might be due to the small size of this
module (N= 72 genes). Although some of the differntialy
expressed genes were significant in the gene-based tests
performed in UKBB-AC and PGC-AD datasets using
MAGMA (CHRNA6, CHRNA2, MN1 and HAPLN1). In
the calcium signaling network (Fig. 3c), a few genes that
were not part of the thistle2 module, but were essential to
create network connections, were also found to be sig-
nificant (3.4 × 10−2 ≤ P ≥ 4.8 × 10−2) in the gene-based
tests (circled in red; Fig. 4c). This suggests possible
gene–environment (alcohol exposure) interactions in the
etiology of alcohol dependence. This also reinforces the
need for multi-omics data to understand a complex dis-
order like alcoholism. eQTLs for genes in the brown4
module (N= 726 genes) were significantly enriched for
GWAS signals (P= 4.2 × 10−3) in the PGC-AD GWAS.
Interestingly this module was also positively correlated
with alcohol dependence (0.18, P= 4.0 × 10−2) in trait-
module correlation analysis.
Because of limited availability of human post-mortem
tissue with DSM4 alcohol dependence phenotype, we
tried to look for validation in rodent RNA-expression
datasets (Supplementary methods; supplementary table
2). The hub genes identified in present analysis were
found to be significant enriched for association signals in
the rodents. This observation adds to the validity of hub
genes in the identified modules.
In the present study, we focused on integrating the
genomic information to transcriptomic data to identify
gene (genetic background) × environment (alcohol expo-
sure) interactions in the etiology of alcohol use disorders.
As mentioned in the discussion we identified that genes
that have altered expression due to alcohol exposure
interact with risk genes (GWAS) to increase an indivi-
dual’s risk of becoming dependent on alcohol. So, to
translate these findings in animals, one has to mimic
expression of hub genes as well as the risk gene to alter
the pathways associated with alcoholism. We are also
reporting the direction of effect of the differential
expression. That should provide information that can be
used to see whether knock-down or overexpression of key
genes alters risk for AUD phenotypes in models. Also, the
replication of the modules in rodent models indicates
which models might be useful to study the effects of
dysregulation in these models.
Multiple lines of evidence derived from this study
allowed us to prioritize the genes altered by exposure to
alcohol. The gene co-expression network analysis also
identified networks of genes altered in alcohol-dependent
subjects. Further support for our findings comes from
work showing that many genes in these networks were
also associated with alcohol dependence and alcohol
consumption in large GWAS study cohorts. This sys-
tematic exploration of transcriptomic organization in the
PFC from alcoholics provides further support for the role
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of the neuroimmune system in alcohol dependence. The
biological pathways and networks of genes identified in
the current study will help prioritize genes for functional
studies and may help advance targeted treatment
approaches for alcohol use disorders.
Data availability
Data sharing policy: RNA-Seq data for alcohol dependence cases and controls
will be available through GEO. All the summary statistics for differential
expression will also be posted at INIA and COGA’s homepage (and Shiny web
app) and will be freely available to download after publication is online. Shiny
webapp link for entire summary statistics: https://lcad.shinyapps.io/coga-inia/
(Access code: coga-inia).
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